6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)-
6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)-
- Catalog No.: 1173381
- Name: 6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)-
- CAS: 39986-26-0
- Formula: C20H26O4
Inquire about this product →
About 6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)-
6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)- is a chemical compound registered under CAS number 39986-26-0, with the molecular formula C20H26O4 and a molecular weight of about 330.42 g/mol. It is also known as (-)-D9-trans-Tetrahydrocannabivarinicacid; Cannabivarinic acid, D9-tetrahydro-; Cannabivarolic acid, D1-tetrahydro-. OrgMetal supplies 6H-Dibenzo[b,d]pyran-2-carboxylicacid, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-3-propyl-, (6aR-trans)- for laboratory research and bulk production; product code 1173381. Send an inquiry for purity, packaging, price and lead time.
- CAS Number
- 39986-26-0
- Molecular Formula
- C20H26O4
- Molecular Weight
- 330.42 g/mol
Synonyms
- (-)-D9-trans-Tetrahydrocannabivarinicacid
- Cannabivarinic acid, D9-tetrahydro-
- Cannabivarolic acid, D1-tetrahydro-
- Tetrahydrocannabivaric
1H-Indole-7-carboxamide,3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[5-[[[[(2S)-tetrahydro-2-furanyl]methyl]amino]methyl]-3-thienyl]-
919340-44-6
1,6,11(2H)-Naphthacenetrione,8-chloro-3,4-dihydro-4,7,12-trihydroxy-3-methyl-, (3R,4R)-rel-
491600-95-4
Glycine, N-[N-[(phenylmethoxy)carbonyl]-L-tryptophyl]-, methyl ester
4910-50-3
Butanamide,2-[2,4-bis(1,1-dimethylpropyl)phenoxy]-N-[3-chloro-2-hydroxy-4-methyl-5-[[(4-methylphenyl)sulfonyl]oxy]phenyl]-
61387-33-5
Butanamide,2-[2,4-bis(1,1-dimethylpropyl)phenoxy]-N-[3-chloro-2-hydroxy-4-methyl-5-[(tetrahydro-2H-pyran-2-yl)oxy]phenyl]-
1H-Indole,2-ethyl-2,3-dihydro-
noradrenochrome
RESTRICTION ENDONUCLEASES SFI I